Conference abstract · 15 Aug 2016
Conference abstractPublished 2 Aug 2017
Helicobacter Pylori Infection : Pathogenesis And Therapeutic Strategies
Sapienza University of Rome, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Helicobacter pylori (Hp) is a Gram-negative mobile bacillus, difficult to be cultured, and able to cause different diseases. In fact Hp is involved in chronic active gastritis, peptic ulcer disease, gastric carcinoma and mucosa-associated lymphoid tissue lymphoma (MALT) other than in endothelial dysfunction leading to vascular diseases. Hp is increasingly difficult to treat. The treatment regimens are declining in efficacy and the therapy of this infection is bedevilled by drug-resistant strains. Aim of our research is to study a population of 50 pangastritis already undergone multiple therapies and to evaluate the eradication rates. Methods: All patients were positive to UBT (Urease Breath Test) then surely infected by Hp. Three biopsies were taken for each patient and submitted to rapid urease test, culture and antibiotics susceptibility by E-test Results:. Out of 50 patients, culture and susceptibility testing were obtained in 31 patients (62%) whereas in 19 (38%) no H. pylori growth was detected. The first group was treated following the scheme shown in the image whereas the second one was empirically treated with antibiotics never taken before or with rescue therapies. The eradication rates were 52% and 63% respectively. Conclusions: No significant difference has been seen between the two groups. Probably the higher eradication rate in patients empirically treated, where no microorganisms have been isolated, can be due to the presence of bacteria not able to grow in culture then in a less virulent or dormant phase or in a very low number to be detected. Anyway, in our study the eradication rates of these pangastritis patients undergone multiple treatments are very low. The Toronto Consensus Group (2016) has proposed new treatment strategies recommending to prolong the cure from 10 to 14 days, to use bismuth quadruple therapy containing metronidazole and tetracycline as well as various rescue therapies.
Subjects
Infectious DiseasesMicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 21 Sep 2020
Pathogenesis of Helicobacter pylori: Case Management Indicator Strategy
Review article · 26 Feb 2014
An overview of pathogenesis and epidemiology of Helicobacter pylori infection
Conference abstract · 7 Feb 2022
Secondary antibiotic resistance, correlation between genotypic and phenotypic methods and treatment in helicobacter pylori infected patients: A retrospective study
Brief report · 2021
A report on Helicobacter pylori infection.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectInfectious Diseases
- SubjectMicrobiology
- BylineArticles whose byline prints “Maria Teresa Mascellino”
